BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19624554)

  • 1. Efficacy of desloratadine in intermittent allergic rhinitis: a GA(2)LEN study.
    Bousquet J; Bachert C; Canonica GW; Mullol J; Van Cauwenberge P; Bindslev Jensen C; Fokkens WJ; Ring J; Keith P; Lorber R; Zuberbier T;
    Allergy; 2009 Oct; 64(10):1516-1523. PubMed ID: 19624554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of desloratadine in persistent allergic rhinitis - a GA²LEN study.
    Bousquet J; Bachert C; Canonica GW; Mullol J; Van Cauwenberge P; Jensen CB; Fokkens WJ; Ring J; Keith P; Gopalan G; Lorber R; Zuberbier T;
    Int Arch Allergy Immunol; 2010; 153(4):395-402. PubMed ID: 20559006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desloratadine treatment for intermittent and persistent allergic rhinitis: a review.
    Bachert C; van Cauwenberge P
    Clin Ther; 2007 Sep; 29(9):1795-802. PubMed ID: 18035184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis.
    Simons FE; Prenner BM; Finn A;
    J Allergy Clin Immunol; 2003 Mar; 111(3):617-22. PubMed ID: 12642846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of desloratadine/pseudoephedrine combination vs its components in seasonal allergic rhinitis.
    Grubbe RE; Lumry WR; Anolik R
    J Investig Allergol Clin Immunol; 2009; 19(2):117-24. PubMed ID: 19476015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion.
    Berger WE; Schenkel EJ; Mansfield LE;
    Ann Allergy Asthma Immunol; 2002 Nov; 89(5):485-91. PubMed ID: 12452207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 24-hour efficacy of once-daily desloratadine therapy in patients with seasonal allergic rhinitis [ISRCTN32042139].
    Salmun LM; Lorber R
    BMC Fam Pract; 2002 Aug; 3():14. PubMed ID: 12162793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of desloratadine, 5 mg, compared with fexofenadine, 180 mg, in patients with symptomatic seasonal allergic rhinitis.
    Berger WE; Lumry WR; Meltzer EO; Pearlman DS
    Allergy Asthma Proc; 2006; 27(3):214-23. PubMed ID: 16913264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of desloratadine on the control of morning symptoms in patients with seasonal and perennial allergic rhinitis.
    Schenkel EJ
    Allergy Asthma Proc; 2006; 27(6):465-72. PubMed ID: 17176780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life in patients with persistent allergic rhinitis treated with montelukast alone or in combination with levocetirizine or desloratadine.
    Ciebiada M; Ciebiada MG; Kmiecik T; DuBuske LM; Gorski P
    J Investig Allergol Clin Immunol; 2008; 18(5):343-9. PubMed ID: 18973097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desloratadine therapy for symptoms associated with perennial allergic rhinitis.
    Kim K; Sussman G; Hébert J; Lumry W; Lutsky B; Gates D
    Ann Allergy Asthma Immunol; 2006 Mar; 96(3):460-5. PubMed ID: 16597081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of desloratadine syrup in children.
    Bloom M; Staudinger H; Herron J
    Curr Med Res Opin; 2004 Dec; 20(12):1959-65. PubMed ID: 15701213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of desloratadine on conjunctival allergen challenge-induced ocular symptoms.
    Torkildsen GL; Gomes P; Welch D; Gopalan G; Srinivasan S
    Clin Exp Allergy; 2009 Jul; 39(7):1052-9. PubMed ID: 19302250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost-effectiveness of treatment with desloratadine in patients with persistent allergic rhinitis.
    Sullivan PW; Navaratnam P; Lorber R; Shekar T
    Curr Med Res Opin; 2010 Jun; 26(6):1389-97. PubMed ID: 20384438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of desloratadine versus montelukast on asthma symptoms and use of beta 2-agonists in patients with seasonal allergic rhinitis and asthma.
    Baena-Cagnani CE; Berger WE; DuBuske LM; Gurné SE; Stryszak P; Lorber R; Danzig M
    Int Arch Allergy Immunol; 2003 Apr; 130(4):307-13. PubMed ID: 12740532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desloratadine relieves nasal congestion and improves quality-of-life in persistent allergic rhinitis.
    Holmberg K; Tonnel AB; Dreyfus I; Olsson P; Cougnard J; Mesbah K; Devillier P
    Allergy; 2009 Nov; 64(11):1663-70. PubMed ID: 19740126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desloratadine improves quality of life and symptom severity in patients with allergic rhinitis.
    Pradalier A; Neukirch C; Dreyfus I; Devillier P
    Allergy; 2007 Nov; 62(11):1331-4. PubMed ID: 17521311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of diphenhydramine vs desloratadine and placebo in patients with moderate-to-severe seasonal allergic rhinitis.
    Raphael GD; Angello JT; Wu MM; Druce HM
    Ann Allergy Asthma Immunol; 2006 Apr; 96(4):606-14. PubMed ID: 16680933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desloratadine for the treatment of cypress pollen-induced allergic rhinitis.
    Demoly P; Dreyfus I; Dhivert-Donnadieu H; Mesbah K
    Ann Allergy Asthma Immunol; 2009 Sep; 103(3):260-6. PubMed ID: 19788025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
    Bachert C
    Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.